Nvidia has surged to become the face of AI, seeing its stock price triple in 2023 while continuing strong performance into 2024, despite competition from other stocks.
Viking Therapeutics represents a promising investment opportunity in the anti-obesity drug sector, competing with major players and potentially offering substantial gains despite the crowded market.
Collection
[
|
...
]